NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain
The National Football League Alumni Association (NFLA), the oldest retired player organization in professional sports, and Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the launch of their partnership to increase awareness of the availability and benefits of non-opioid options to manage acute and chronic pain, including postsurgical pain and knee osteoarthritis (OA).
The program seeks to educate retired players, NFLA chapter presidents and staff, youth sports organizations including Play 60, Pop Warner, and the Amateur Athletic Union (AAU) about the importance of non-opioid pain management options that can reduce or eliminate the need for opioids, which can be associated with unwanted and potentially severe side effects.
The partnership will include educational opportunities at NFLA state and local chapter events, as well as national tournaments throughout the year including the Super Bowl, Pro Bowl, Super Bowl of Golf, the Red, White, & Blue Celebrity Golf Classic, and the NFLA Super Bowl Pro-Am.
“I have firsthand personal knowledge of the value our partnership with Pacira BioSciences will bring to our members,” said Beasley Reese, CEO of NFL Alumni. “Pacira Biosciences’ products dramatically reduced the amount of pain my wife Paula experienced when she underwent knee replacement surgery. She used fewer dangerous narcotics and experienced less pain while going through that difficult operation and rehabilitation. Her knee was still numb two months after a pain block procedure, and she was able to rehab harder and faster because of Pacira Biosciences’ products. Opioids can have terrible side effects and NFL Alumni members will use fewer dangerous drugs and have better outcomes thanks to this partnership.”
Educational content and resources will also be shared with athletes and their families through NFLA newsletters, social media channels, and corporate meetings.
The program will launch this fall with various events and activations concluding in May 2025.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
